Cargando…

AD Course Map charts Alzheimer’s disease progression

Alzheimer’s disease (AD) is characterized by the progressive alterations seen in brain images which give rise to the onset of various sets of symptoms. The variability in the dynamics of changes in both brain images and cognitive impairments remains poorly understood. This paper introduces AD Course...

Descripción completa

Detalles Bibliográficos
Autores principales: Koval, Igor, Bône, Alexandre, Louis, Maxime, Lartigue, Thomas, Bottani, Simona, Marcoux, Arnaud, Samper-González, Jorge, Burgos, Ninon, Charlier, Benjamin, Bertrand, Anne, Epelbaum, Stéphane, Colliot, Olivier, Allassonnière, Stéphanie, Durrleman, Stanley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044144/
https://www.ncbi.nlm.nih.gov/pubmed/33850174
http://dx.doi.org/10.1038/s41598-021-87434-1
_version_ 1783678424185831424
author Koval, Igor
Bône, Alexandre
Louis, Maxime
Lartigue, Thomas
Bottani, Simona
Marcoux, Arnaud
Samper-González, Jorge
Burgos, Ninon
Charlier, Benjamin
Bertrand, Anne
Epelbaum, Stéphane
Colliot, Olivier
Allassonnière, Stéphanie
Durrleman, Stanley
author_facet Koval, Igor
Bône, Alexandre
Louis, Maxime
Lartigue, Thomas
Bottani, Simona
Marcoux, Arnaud
Samper-González, Jorge
Burgos, Ninon
Charlier, Benjamin
Bertrand, Anne
Epelbaum, Stéphane
Colliot, Olivier
Allassonnière, Stéphanie
Durrleman, Stanley
author_sort Koval, Igor
collection PubMed
description Alzheimer’s disease (AD) is characterized by the progressive alterations seen in brain images which give rise to the onset of various sets of symptoms. The variability in the dynamics of changes in both brain images and cognitive impairments remains poorly understood. This paper introduces AD Course Map a spatiotemporal atlas of Alzheimer’s disease progression. It summarizes the variability in the progression of a series of neuropsychological assessments, the propagation of hypometabolism and cortical thinning across brain regions and the deformation of the shape of the hippocampus. The analysis of these variations highlights strong genetic determinants for the progression, like possible compensatory mechanisms at play during disease progression. AD Course Map also predicts the patient’s cognitive decline with a better accuracy than the 56 methods benchmarked in the open challenge TADPOLE. Finally, AD Course Map is used to simulate cohorts of virtual patients developing Alzheimer’s disease. AD Course Map offers therefore new tools for exploring the progression of AD and personalizing patients care.
format Online
Article
Text
id pubmed-8044144
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-80441442021-04-14 AD Course Map charts Alzheimer’s disease progression Koval, Igor Bône, Alexandre Louis, Maxime Lartigue, Thomas Bottani, Simona Marcoux, Arnaud Samper-González, Jorge Burgos, Ninon Charlier, Benjamin Bertrand, Anne Epelbaum, Stéphane Colliot, Olivier Allassonnière, Stéphanie Durrleman, Stanley Sci Rep Article Alzheimer’s disease (AD) is characterized by the progressive alterations seen in brain images which give rise to the onset of various sets of symptoms. The variability in the dynamics of changes in both brain images and cognitive impairments remains poorly understood. This paper introduces AD Course Map a spatiotemporal atlas of Alzheimer’s disease progression. It summarizes the variability in the progression of a series of neuropsychological assessments, the propagation of hypometabolism and cortical thinning across brain regions and the deformation of the shape of the hippocampus. The analysis of these variations highlights strong genetic determinants for the progression, like possible compensatory mechanisms at play during disease progression. AD Course Map also predicts the patient’s cognitive decline with a better accuracy than the 56 methods benchmarked in the open challenge TADPOLE. Finally, AD Course Map is used to simulate cohorts of virtual patients developing Alzheimer’s disease. AD Course Map offers therefore new tools for exploring the progression of AD and personalizing patients care. Nature Publishing Group UK 2021-04-13 /pmc/articles/PMC8044144/ /pubmed/33850174 http://dx.doi.org/10.1038/s41598-021-87434-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Koval, Igor
Bône, Alexandre
Louis, Maxime
Lartigue, Thomas
Bottani, Simona
Marcoux, Arnaud
Samper-González, Jorge
Burgos, Ninon
Charlier, Benjamin
Bertrand, Anne
Epelbaum, Stéphane
Colliot, Olivier
Allassonnière, Stéphanie
Durrleman, Stanley
AD Course Map charts Alzheimer’s disease progression
title AD Course Map charts Alzheimer’s disease progression
title_full AD Course Map charts Alzheimer’s disease progression
title_fullStr AD Course Map charts Alzheimer’s disease progression
title_full_unstemmed AD Course Map charts Alzheimer’s disease progression
title_short AD Course Map charts Alzheimer’s disease progression
title_sort ad course map charts alzheimer’s disease progression
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044144/
https://www.ncbi.nlm.nih.gov/pubmed/33850174
http://dx.doi.org/10.1038/s41598-021-87434-1
work_keys_str_mv AT kovaligor adcoursemapchartsalzheimersdiseaseprogression
AT bonealexandre adcoursemapchartsalzheimersdiseaseprogression
AT louismaxime adcoursemapchartsalzheimersdiseaseprogression
AT lartiguethomas adcoursemapchartsalzheimersdiseaseprogression
AT bottanisimona adcoursemapchartsalzheimersdiseaseprogression
AT marcouxarnaud adcoursemapchartsalzheimersdiseaseprogression
AT sampergonzalezjorge adcoursemapchartsalzheimersdiseaseprogression
AT burgosninon adcoursemapchartsalzheimersdiseaseprogression
AT charlierbenjamin adcoursemapchartsalzheimersdiseaseprogression
AT bertrandanne adcoursemapchartsalzheimersdiseaseprogression
AT epelbaumstephane adcoursemapchartsalzheimersdiseaseprogression
AT colliotolivier adcoursemapchartsalzheimersdiseaseprogression
AT allassonnierestephanie adcoursemapchartsalzheimersdiseaseprogression
AT durrlemanstanley adcoursemapchartsalzheimersdiseaseprogression